Additionally, we performed ROC curve analysis to identify the cut-off value of Ang2 and ANGPTL8 and to further evaluate the predictive accuracy of these biomarkers for people with DN (Figure 3). The gene discussed is ANGPT2; the disease is liver dysplastic nodule.